RhumbLine Advisers
TIL icon

RhumbLine Advisers’s Instil Bio TIL Stock Holding History

RhumbLine Advisers’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-114
Closed -$939 – 4253
2026
Q1 		$939 Hold
114
– – ﹤0.01% 3981
2025
Q4 		$1.25K Hold
114
– – ﹤0.01% 4021
2025
Q3 		$2.04K Hold
114
– – ﹤0.01% 3988
2025
Q2 		$2.37K Hold
114
– – ﹤0.01% 3983
2025
Q1 		$1.98K Hold
114
– – ﹤0.01% 3989
2024
Q4 		$2.18K Hold
114
– – ﹤0.01% 4034
2024
Q3 		$7.67K Hold
114
– – ﹤0.01% 3922
2024
Q2 		$1.17K Hold
114
– – ﹤0.01% 4229
2024
Q1 		$1.23K Hold
114
– – ﹤0.01% 4130
2023
Q4 		$868 Sell
114
-1
-0.9% -$7 ﹤0.01% 4160
2023
Q3 		$980 Sell
115
-428
-79% -$4.31K ﹤0.01% 4184
2023
Q2 		$5.98K Sell
543
-4,780
-90% -$58.4K ﹤0.01% 4055
2023
Q1 		$70K Buy
5,323
+111
+2% +$1.64K ﹤0.01% 2893
2022
Q4 		$66K Sell
5,212
-18
-0.3% -$890 ﹤0.01% 2934
2022
Q3 		$506K Buy
5,230
+291
+6% +$33.3K ﹤0.01% 2486
2022
Q2 		$456K Buy
4,939
+1,817
+58% +$257K ﹤0.01% 2541
2022
Q1 		$671K Buy
3,122
+183
+6% +$42.8K ﹤0.01% 2288
2021
Q4 		$1.01M Buy
2,939
+2,087
+245% +$806K ﹤0.01% 2206
2021
Q3 		$305K Buy
852
+50
+6% +$18.7K ﹤0.01% 2758
2021
Q2 		$310K Buy
+802
New +$297K ﹤0.01% 2774

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

RhumbLine Advisers's TIL Position: Q2 2026 in Review

RhumbLine Advisers sold out of Instil Bio (TIL) in Q2 2026, closing a stake of 114 shares — an estimated $939 sold.

RhumbLine Advisers first reported a position in TIL in Q2 2021 and held it in 20 quarters. The position peaked at $1.01M in Q4 2021. 26 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • RhumbLine Advisers reported no remaining Instil Bio position as of Q2 2026 after selling out during the quarter.
  • RhumbLine Advisers sold 114 Instil Bio shares in Q2 2026, an estimated $939.
  • RhumbLine Advisers first reported a position in Instil Bio in Q2 2021 and held it in 20 quarters.
  • RhumbLine Advisers's Instil Bio position peaked at $1.01M in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.